Zymeworks (ZYME) to Offer Common Stock and Pre-Funded Warrant

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/21/2026

1. SPCX
2. NVDA
3. NFLX
4. ISRG
5. META
6. TSLA
7. SMCI
8. RTX
9. S
10. COF

Go back to Zymeworks (ZYME) to Offer Common Stock and Pre-Funded Warrant

Zymeworks Files Preliminary Prospectus Supplements for Offering of Common Shares and Pre-Funded Warrants

January 21, 2020 4:08 PM EST

VANCOUVER, British Columbia---(BUSINESS WIRE)-- Zymeworks Inc. (NYSE: ZYME) (Zymeworks or the Company), a clinicalstage biopharmaceutical company developing multifunctional biotherapeutics, has today filed a preliminary prospectus supplement (the Canadian Supplement) to its Canadian short form base shelf prospectus dated November 18, 2019 (the Base Prospectus) in connection with an offering of its common shares and, in lieu of common shares to a certain investor, pre-funded warrants to purchase its common shares (the Offering). The Canadian Supplement was filed with the securities regulatory authorities in each of the provinces and territories of Canada. A preliminary... More